An alternative protein standard to measure activity of LOX-1 ligand containing apoB (LAB) - utilization of anti-LOX-1 single-chain antibody fused to apoB fragment

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 9, 2011, Pages 818-828

  Iwamoto, Shin ^a,b   Fujita, Yoshiko ^a   Kakino, Akemi ^a,b   Yanagida, Kazuki ^a,c   Matsuda, Haruo ^d   Yoshimoto, Ryo ^a   Sawamura, Tatsuya ^a,b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Biomarker Science Co Ltd   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Anti apoB antibody; ELISA; LOX 1; Oxidized LDL

Indexed keywords

APOLIPOPROTEIN B; BINDING PROTEIN; COMPLEMENTARY DNA; COPPER OXIDE; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION;

AMINO ACID SEQUENCE; APOLIPOPROTEIN B-48; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; SCAVENGER RECEPTORS, CLASS E;

EID: 80053191121     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.9142     Document Type: Article

References (33)

1. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest, 1991; 88: 1785-1792
2. Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem, 1997; 272: 20963-20906
3. Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV: Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int, 2005; 68: 173-178
4. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL: Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med, 2007; 13: 1176-1184
5. Younis N, Sharma R, Soran H, Charlton-Menys V, Elseweidy M, Durrington PN: Glycation as an atherogenic modification of LDL. Curr Opin Lipidol, 2008; 19: 378-384
6. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T: An endothelial receptor for oxidized low-density lipoprotein. Nature, 1997; 386: 73-77
7. Navarra T, Del Turco S, Berti S, Basta G: The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. Journal of Atherosclerosis and Thrombosis, 2010; 17: 317-331
8. Apostolov EO, Shah SV, Ray D, Basnakian AG: Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler Thromb Vasc Biol, 2009; 29: 1622-1630
9. Lu J, Yang J-H, Burns AR, Chen H-H, Tang D, Walterscheid JP, Suzuki S, Yang C-Y, Sawamura T, Chen C-H: Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis. Circ Res, 2009; 104: 619-627
10. Chen M, Masaki T, Sawamura T: LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther, 2002; 95: 89-100
11. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, Sawamura T, Masaki T, Hashimoto N, Kita T: Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation, 1999; 99: 3110-3117
12. Chen M, Kakutani M, Minami M, Kataoka H, Kume N, Narumiya S, Kita T, Masaki T, Sawamura T: Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol, 2000; 20: 1107-1115
13. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue K, Kawase Y, Jishage K, Suzuki H, Takeya M, Schnackenberg L, Beger R, Hermonat PL, Thomas M, Sawamura T: Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res, 2007; 100: 1634-1642
14. Hu C, Chen J, Dandapat A, Fujita Y, Inoue N, Kawase Y, Jishage K, Suzuki H, Li D, Hermonat PL, Sawamura T, Mehta JL: LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. J Mol Cell Cardiol, 2008; 44: 76-83
15. Nakano A, Inoue N, Sato Y, Nishimichi N, Takikawa K, Fujita Y, Kakino A, Otsui K, Yamaguchi S, Matsuda H, Sawamura T: LOX-1 mediates vascular lipid retention under hypertensive state. J Hypertens, 2010; 28: 1273-1280
16. Sato Y, Nishimichi N, Nakano A, Takikawa K, Inoue N, Matsuda H, Sawamura T: Determination of LOX-1-ligand activity in mouse plasma with a chicken monoclonal antibody for ApoB. Atherosclerosis, 2008; 200: 303-309
17. Inoue N, Okamura T, Kokubo Y, Fujita Y, Sato Y, Nakanishi M, Yanagida K, Kakino A, Iwamoto S, Watanabe M, Ogura S, Otsui K, Matsuda H, Uchida K, Yoshimoto R, Sawamura T: LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem, 2010; 56: 550-558
18. Oka K, Yasuhara M, Suzumura K, Tanaka K, Sawamura T: Antioxidants suppress plasma levels of lectinlike oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in watanabe heritable hyperlipidemic rabbits. J Cardiovasc Pharmacol, 2006; 48: 177-183
19. Kakutani M, Ueda M, Naruko T, Masaki T, Sawamura T: Accumulation of LOX-1 ligand in plasma and atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits: identification by a novel enzyme immunoassay. Biochem Biophys Res Commun, 2001; 282: 180-185
20. Hörkkö S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest, 1996; 98: 815-825
21. Holvoet P, Van Cleemput J, Collen D, Vanhaecke J: Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol, 2000; 20: 698-702
22. Itabe H, Ueda M: Measurement of plasma oxidized lowdensity lipoprotein and its clinical implications. J Atheroscler Thromb, 2007; 14: 1-11
23. Tanigawa H, Miura S, Zhang B, Uehara Y, Matsuo Y, Fujino M, Sawamura T, Saku K: Low-density lipoprotein oxidized to various degrees activates ERK1/2 through Lox-1. Atherosclerosis, 2006; 188: 245-250
24. Sugimoto K, Ishibashi T, Sawamura T, Inoue N, Kamioka M, Uekita H, Ohkawara H, Sakamoto T, Sakamoto N, Okamoto Y, Takuwa Y, Kakino A, Fujita Y, Tanaka T, Teramoto T, Maruyama Y, Takeishi Y: LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovasc Res, 2009; 84: 127-136
25. Kabat EA, Wu TT, Reid-Miller M, Perry HM, Gottesman KS, Foeller C: Sequences of proteins of immunological interest. 5th ed US Department of Health and Human Services, Public Service, NIH, Washington, DC, USA, 1991
26. Pease RJ, Milne RW, Jessup WK, Law A, Provost P, Fruchart JC, Dean RT, Marcel YL, Scott J: Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. J Biol Chem, 1990; 265: 553-568
27. Segrest JP, Jones MK, De Loof H, Dashti N: Structure of apolipoprotein B-100 in low density lipoproteins. J Lipid Res, 2001; 42: 1346-1367
28. Tanaga K, Bujo H, Inoue M, Mikami K, Kotani K, Takahashi K, Kanno T, Saito Y: Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol, 2002; 22: 662-666
29. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE: Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 2001; 103: 1955-1960
30. Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, Nagahiro S: Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol, 2002; 22: 1649-1654
31. Itabe H, Takeshima E, Iwasaki H, Kimura J, Yoshida Y, Imanaka T, Takano T: A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerosis. J Biol Chem, 1994; 269: 15274-15279
32. Marsche G, Levak-Frank S, Quehenberger O, Heller R, Sattler W, Malle E: Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells. FASEB J, 2001; 15: 1095-1097
33. Shin HK, Kim YK, Kim KY, Lee JH, Hong KW: Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via Lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation, 2004; 109: 1022-1028